Lupin Pharmaceuticals Inc. is recalling 32,736 vials of Ganirelix Acetate Injection (250 mcg/0.5mL) due to the presence of an impurity called an acrylic acid adduct that exceeds safety specifications. This medication is a prescription injectable used in fertility treatments and was distributed in prefilled syringes. Consumers who have this medication should check their lot number and contact their healthcare provider immediately.
The product contains impurities that fell out of the required quality specifications during testing, which may affect the safety or efficacy of the medication. While no specific injuries have been reported, using medication with unexpected degradation products can pose health risks or lead to unexpected side effects.
You have 2 options:
Recall #: D-0220-2026; Quantity: 32736 vials
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.